(PharmaNewsWire.Com, January 03, 2017 ) Digital pathology by definition is an image-based information environment for management, analysis, and interpretation of the medical information achieved from a digital slide. In a nutshell, the digitalization of conventional pathology lab is referred as digital pathology. This technology has gained momentum in the global medical and healthcare industry, due to the improvements it brings in a number of applications such as drug discoveries, development of multi-functional devices, diagnostic tests and other research purposes.
Increasing no. of cancer cases, growing presence of tele-consultations, high efficacy of digital pathology systems with increased adoption rate and more initiatives undertook by government as well as private companies are helping the cause of the digital pathology market. On the other hand, barriers such as strict regulatory concerns for primary diagnosis, lack of standard guidelines for digital pathology, nonexistence of reimbursement and deficiency in skilled personnel are some of the major factors that are constraining the market in all likelihood. However, mounting requirement for sophisticated healthcare facilities which can be met through establishing digital pathology systems, would offer lucrative opportunities for the service providers in the future if they can overcome threats like high cost of installing new technology or building new infrastructure.
Some of the key players operating in the market include Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd, Hamamatsu Photonics, K.K., Digipath Co., ZEISS, Olympus Corporation, Yokogawa Electronic Corporation and Quorum Technologies Inc.
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: